ISTODAX Trademark

Trademark Overview

On Friday, August 22, 2008, a trademark application was filed for ISTODAX with the United States Patent and Trademark Office. The USPTO has given the ISTODAX trademark a serial number of 79058882. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Monday, April 9, 2018. This trademark is owned by Astellas Pharma Inc.. The ISTODAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations as an anti-cancer drug for human uses
istodax

General Information

Serial Number79058882
Word MarkISTODAX
Filing DateFriday, August 22, 2008
Status706 - SECTION 71 ACCEPTED
Status DateMonday, April 9, 2018
Registration Number3598805
Registration DateTuesday, March 31, 2009
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 13, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations as an anti-cancer drug for human uses
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 17, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressSummit, NJ 07901
Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Friday, September 8, 2023NEW REPRESENTATIVE AT IB RECEIVED
Saturday, May 8, 2021NEW REPRESENTATIVE AT IB RECEIVED
Thursday, September 6, 2018INTERNATIONAL REGISTRATION RENEWED
Monday, April 9, 2018NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, April 9, 2018REGISTERED-SEC.71 ACCEPTED
Monday, April 2, 2018TEAS SECTION 71 RECEIVED
Saturday, March 31, 2018COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, September 10, 2015NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 8, 2014NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Thursday, May 8, 2014REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Tuesday, April 1, 2014REGISTERED - SEC. 71 & SEC. 15 FILED
Wednesday, May 7, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 1, 2014TEAS SECTION 71 & 15 RECEIVED
Monday, March 31, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 31, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 12, 2011CHANGE OF OWNER RECEIVED FROM IB
Tuesday, March 31, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, January 13, 2009PUBLISHED FOR OPPOSITION
Wednesday, December 24, 2008NOTICE OF PUBLICATION
Wednesday, December 10, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 10, 2008ASSIGNED TO LIE
Wednesday, December 3, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 2, 2008ASSIGNED TO EXAMINER
Tuesday, October 21, 2008APPLICATION FILING RECEIPT MAILED
Friday, October 17, 2008NEW APPLICATION ENTERED
Thursday, October 16, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

istodax human uses drug cancer preparations anti pharmaceutical